Skip to main content

August 2016

 

 

academics

 

Clinical research courses

Wanted Principal Scientist - Nonclinical Safety at Abbott

Abbott is about the power of health. For more than 125 years, Abbott has been helping people reach their potential — because better health allows people and communities to achieve more. With a diverse, global network serving customers in more than 150 countries, we create new solutions — across the spectrum of health, around the world, for all stages of life. Whether it’s next-generation diagnostics, life-changing devices, science-based nutrition, or novel reformulations, we are advancing some of the most innovative and revolutionary technologies in healthcare, helping people live their best lives through better health.

Post: Principal Scientist Nonclinical Safety

Required Regional Sales Executive at Johnson & Johnson

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products. The organization is comprised of more than 250 operating companies with over 128,000 employees located in some 60 countries. With Global sales of USD 67.2 billion in 2012, Johnson & Johnson is recognized as one of the most admired and respected companies in the world.  In India, Johnson & Johnson operates as a single legal entity and consists of the 3 strategic business units: Consumer Products, Pharmaceuticals and Medical Devices & Diagnostics, which are independently managed and report into their respective Global business segments.  Ethicon Endo-Surgery is part of the Johnson & Johnson Family of Companies. We not only represent a history of innovation, but a rich tradition of patient care that begins with our parent company, Johnson & Johnson.

Post : REGIONAL SALES EXECUTIVE

Career as Scientist at National Institute of Mental Health and Neuro Sciences | Pay Band Up to Rs 56,000

The National Institute of Mental Health and Neuro Sciences is a multidisciplinary Institute for patient care and academic pursuit in the frontier area of Mental Health and Neuro Sciences. The Lunatic Asylum which came into being in the latter part of the 19th Century was renamed as Mental Hospital in 1925 by the erstwhile Government of Mysore. This hospital and All India Institute of Mental Health established in 1954 by the Government of India were amalgamated on 27th December 1974, and thus was formed the autonomous National Institute of Mental Health and Neuro Sciences (NIMHANS). The priority gradient adopted by the Institute is service, manpower development and research. Multidisciplinary integrated approach is the mainstay of this Institute, paving the way to translate the results from bench to bedside. On November 14, 1994, NIMHANS was accorded the status of Deemed University by the University Grants Commission, with academic autonomy.

Applications are invited from the eligible candidates for the following posts from the desirous candidates who fulfill the below mentioned criterion on contract basis under the Department of Neuroimaging and Interventional Radiology of this Institute.

Post : Scientist

Walk in Interview for the post of Project JRF under ‘DIHAR (DRDO) CARS’ at Institute of Nano Science and Technology- M.Pharm/MS Pharm

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed. The institute is currently operating from its transit campus at Habitat Centre, Sector-64, Phase-X, Mohali, Punjab. The new campus of INST would be set up on 35 acers of land in the Knowledge City at Sector-81 (Mohali, Punjab), next to IISER Mohali campus, which is very near to new Chandigarh International Airport. INST, amongst other scientific institutions of Chandigarh and its nearby area is also part of Chandigarh Region Innovation and Knowledge Cluster (CRIKC), an initiative of Punjab Government to foster and sustain close academic alliances between institutions of higher education and research in the Chandigarh region.

Walk-In-Interview will be conducted in Institute of Nano Science and Technology, Mohali, on 19th August 2016 at 11:00 AM to select one Project JRF in “DIHAR(DRDO) CARS” project.

Application are invited for the post of Research Associate in GGSIU - Ph.D in Ph. Chemistry / Pharmacology / Medicinal Chemistry

Guru Gobind Singh Indraprastha University is a dynamic growth oriented organization established to facilitate and promote studies and research in emerging areas of higher education with focus on professional education. The University imparts education in the field of Engineering, Science, Technology, Humanities & Social Sciences etc. at Graduate, Post-Graduate, and Doctorate Level under its various Schools.

Job as Clinical Process Analyst, Clinical in Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics - ensuring a higher level of healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.

Dynavax Technologies Corporation  announced that the Vaccines and Related Biological Products Advisory Committee (VBRPAC) will review the Biologics License Application (BLA) for HEPLISAV-B™ [Hepatitis B Vaccine, Recombinant (Adjuvanted)] at its meeting on November 16, 2016. The FDA has indicated it will communicate questions for the VRBPAC to address closer in time to the meeting date. HEPLISAV-B, the company's vaccine candidate for immunization against infection caused by all known subtypes of hepatitis B virus in adults ages 18 years of age and older, is currently under FDA review, with a December 15, 2016 Prescription Drug User Fee Act (PDUFA) action date.

Allergan plc, a leading global pharmaceutical company, and Gedeon Richter Plc. provided a clinical and regulatory update on cariprazine. For more than a decade both companies have conducted over 20 clinical trials enrolling thousands of patients worldwide to evaluate the efficacy and safety of cariprazine for patients suffering from a broad range of mental health illnesses.  

(adsbygoogle = window.adsbygoogle || []).push({});